Veterinary Medicines

Imoxicate 40 mg/10 mg spot-on solution for small dogs

Authorised
This information is not available for this product.
Download as PDF

Product identification

Medicine name:
Imoxicate 40 mg/10 mg spot-on solution for small dogs
Imoxicate 40 mg/10 mg Lösung zum Auftropfen für kleine Hunde
Active substance:
This information is not available for this product.
Target species:
  • Dog
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Spot-on use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AB52
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:
  • A white polypropylene (PP) unit dose pipette with a closure with a spike composed of high density polyethylene (HDPE) orpolyoxymethylene (POM) or polypropylene (PP) packed into a laminated triplex bag composed of polyester (PETP), aluminium(Al) and low density polyetylene (LDPE).Cardboard box containing 1 pipette.
  • A white polypropylene (PP) unit dose pipette with a closure with a spike composed of high density polyethylene (HDPE) orpolyoxymethylene (POM) or polypropylene (PP) packed into a laminated triplex bag composed of polyester (PETP), aluminium(Al) and low density polyetylene (LDPE).Cardboard box containing 3 pipettes.
  • A white polypropylene (PP) unit dose pipette with a closure with a spike composed of high density polyethylene (HDPE) orpolyoxymethylene (POM) or polypropylene (PP) packed into a laminated triplex bag composed of polyester (PETP), aluminium(Al) and low density polyetylene (LDPE).Cardboard box containing 4 pipettes.
  • A white polypropylene (PP) unit dose pipette with a closure with a spike composed of high density polyethylene (HDPE) orpolyoxymethylene (POM) or polypropylene (PP) packed into a laminated triplex bag composed of polyester (PETP), aluminium(Al) and low density polyetylene (LDPE).Cardboard box containing 6 pipettes.
  • A white polypropylene (PP) unit dose pipette with a closure with a spike composed of high density polyethylene (HDPE) orpolyoxymethylene (POM) or polypropylene (PP) packed into a laminated triplex bag composed of polyester (PETP), aluminium(Al) and low density polyetylene (LDPE).Cardboard box containing 24 pipettes.
  • A white polypropylene (PP) unit dose pipette with a closure with a spike composed of high density polyethylene (HDPE) orpolyoxymethylene (POM) or polypropylene (PP) packed into a laminated triplex bag composed of polyester (PETP), aluminium(Al) and low density polyetylene (LDPE).Cardboard box containing 48 pipettes.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • Tad Pharma GmbH
  • Krka d.d. Novo Mesto
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 402663.00.00
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0565/003
Concerned member states:
  • Germany

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."